Mysscat, I really do not see anything positive about the stock at all. I sold when I figured out that Moro had been exaggerating the value of RECAF. Abbott leaving absolutely drove a nail in the coffin for the product. Moro apparently cannot get any licensees for the ELISA test in over 10 months. China is building regulatory walls higher each day so they can be considered an equal to the FDA and capture most all of the medical device manufacturing for export. The FDA now even has offices in China. The whole China venture was expensive and is a lost cause.
If you are looking for something positive, I am certainly not the one to ask. Right now, I cannot think of one positive aspect of owning or buying this stock. Even if Inverness does proceed which I highly doubt, Smithline will be the only one to benefit because he will have all the assets. The only thing left of value in the company is a stock price of 6 cents and unless the volume drops significantly, that value is going to zero also as the employees attempt to sell their shares.
Moro has also stopped answering questions on the company board. He is now only going to give shareholders information via appropriate channels. I would take that to mean press releases or filings. My personal opinion of that is that he does not want any more liability from continued comments on the company board.
AI
